In this issue:
FDG-PET/CT for initial staging in stage I/IIA, HER2-positive breast cancer or TNBC
DATA trial: ovarian function recovery with adjuvant anastrozole
Intra-biopsy injection to reduce pro-metastatic changes in a mouse model
Gut microbiota & pCR with neoadjuvant chemotherapy for breast cancer
CDK4/6 inhibitor retrial after prior CDK4/6 inhibitor failure in ER-positive metastatic breast cancer
Brain metastases in HER2-positive breast cancer with neoadjuvant trastuzumab + pertuzumab
IPATunity130 trial: ipatasertib + paclitaxel in metastatic TNBC with PIK3CA/AKT1/PTEN alterations
EMERALD trial: benefit of elacestrant by prior duration of endocrine therapy + CDK4/6 inhibitor
MammaPrint assay to predict benefit from extended letrozole therapy
Universal genetic testing in newly diagnosed breast cancer
Please login below to download this issue (PDF)